Praxis Precision Medicines Statistics Share Statistics Praxis Precision Medicines has 21.05M
shares outstanding. The number of shares has increased by 12.92%
in one year.
Shares Outstanding 21.05M Shares Change (YoY) 12.92% Shares Change (QoQ) 3.32% Owned by Institutions (%) 99.99% Shares Floating 19.81M Failed to Deliver (FTD) Shares 7 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 2.38M, so 11.32% of the outstanding
shares have been sold short.
Short Interest 2.38M Short % of Shares Out 11.32% Short % of Float 11.34% Short Ratio (days to cover) 4.88
Valuation Ratios The PE ratio is -7.54 and the forward
PE ratio is -4.22.
Praxis Precision Medicines's PEG ratio is
0.17.
PE Ratio -7.54 Forward PE -4.22 PS Ratio 161.13 Forward PS 77.8 PB Ratio 3.09 P/FCF Ratio -10.46 PEG Ratio 0.17
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Praxis Precision Medicines.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 10.77,
with a Debt / Equity ratio of 0.
Current Ratio 10.77 Quick Ratio 10.77 Debt / Equity 0 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $73.73K Profits Per Employee $-1.58M Employee Count 116 Asset Turnover 0.02 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -16.76% in the
last 52 weeks. The beta is 2.62, so Praxis Precision Medicines's
price volatility has been higher than the market average.
Beta 2.62 52-Week Price Change -16.76% 50-Day Moving Average 47.89 200-Day Moving Average 51.09 Relative Strength Index (RSI) 69.05 Average Volume (20 Days) 481,396
Income Statement In the last 12 months, Praxis Precision Medicines had revenue of 8.55M
and earned -182.82M
in profits. Earnings per share was -10.21.
Revenue 8.55M Gross Profit 8.2M Operating Income -200.16M Net Income -182.82M EBITDA -199.81M EBIT -200.16M Earnings Per Share (EPS) -10.21
Full Income Statement Balance Sheet The company has 215.37M in cash and 1.37M in
debt, giving a net cash position of 214M.
Cash & Cash Equivalents 215.37M Total Debt 1.37M Net Cash 214M Retained Earnings -836.74M Total Assets 452.83M Working Capital 257.97M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -131.76M
and capital expenditures 0, giving a free cash flow of -131.76M.
Operating Cash Flow -131.76M Capital Expenditures n/a Free Cash Flow -131.76M FCF Per Share -7.36
Full Cash Flow Statement Margins Gross margin is 95.81%, with operating and profit margins of -2340.29% and -2137.48%.
Gross Margin 95.81% Operating Margin -2340.29% Pretax Margin -2137.48% Profit Margin -2137.48% EBITDA Margin -2336.1% EBIT Margin -2340.29% FCF Margin -1540.48%
Dividends & Yields PRAX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for PRAX is $84,
which is 52.2% higher than the current price. The consensus rating is "Buy".
Price Target $84 Price Target Difference 52.2% Analyst Consensus Buy Analyst Count 9
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Nov 29, 2023. It was a
backward
split with a ratio of 1:15.
Last Split Date Nov 29, 2023 Split Type backward Split Ratio 1:15
Scores Altman Z-Score 8.29 Piotroski F-Score 2
